You may also like these news :
GlaxoSmithKline's shares pressured after forecast, results
British drugmaker GlaxoSmithKline on Thursday reported a 12% profit fall in fourth-quarter profit and said this year's earnings would drop as well, hurt by declining sales of diabetes drug Avandia as well as copycat competition. Shares of Europe's largest drugmaker tumbled 6.9% in London after the release of the results, touching levels not seen since August 2004.